G. Giuberti

Percutaneous Ethanol Injection Efficacy in the Treatment of Large Symptomatic Thyroid Cystic Nodules: Ten-Year Follow-Up of a Large Series

Salvatore Del Prete, Michele Caraglia, Giovanni Vitale et al. · Thyroid · 2002 · 131 citations

Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR

Michele Caraglia, G. Giuberti, Maurizio Marra et al. · Cell Death and Disease · 2011 · 97 citations · Full text

Octreotide Lar, Hepatology, Hepatocellular Carcinoma Patients +15

Interferon-α induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor

Michele Caraglia, A. Abbruzzese, A. Leardi et al. · Cell Death and Differentiation · 1999 · 74 citations · Full text

Inflammation, Cytokine, Epidermal Growth Factor +13

The farnesyl transferase inhibitor R115777 (Zarnestra®) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa®) and Pamidronate

Michele Caraglia, Anna Maria D’Alessandro, Monica Marra et al. · Oncogene · 2004 · 74 citations

Molecular Pharmacology, Medicinal Chemistry, Zoledronic Acid +12

EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-α-mediated apoptosis in epidermoid cancer cells

Michele Caraglia, Pierosandro Tagliaferri, Monica Marra et al. · Cell Death and Differentiation · 2003 · 59 citations · Full text

Cancer Research, Inducible Survival Response, Signaling Pathway +14